Clinical Trial

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-11.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-05-05
Trial Details
NCT Number NCT07302815
Lead Sponsor Tanta University
Conditions Emergence Agitation
Enrollment 120 participants
Start Date 2026-01-10
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-06